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Uric acid saturation in calcium nephrolithiasis. Hyperuricosuria 
appears to cause calcium oxalate nephrolithiasis by promoting 
the formation of monosodium ilrate or uric acid crystals, which 
either act as seed crystals for calcium oxalate or adsorb normally 
occurring macromolecular inhibitors of calcium oxalate crystalli- 
zation. Both mechanism5 require thiit hyperuricosuria cause ex- 
cessive supersaturation of the urine. but this has not yet been 
studied under conditions of normal lifestyle. We have measured 
the saturation with respect to sodium hydrogen urate and the 
concentration of undissociated uric acid in the urine samples of 
67 patients with calcium nephrolithiasis, who had idiopathic hy- 
percalciuria, hyperuricosuria, both. or neither disorder. Patients 
with hypenlricosuria excreted urine that was supersaturated 
with respect to monosodium urate or undissociated uric acid 
more frequently than did other stone formers or normal subjects, 
and are therefore at a greater risk of forming a solid phase of 
monosodium urate or uric acid. Treatment measures that low- 
ered uric acid excretion also lowered urine saturation, and this 
may be the reason that such treatment tends to prevent calcium 
stone recurrence. 
Solution saturee d'acide urique dans la lithiase calcique. 
1~'hyperuricosurie semble determiner des lithiases d'oxalate de 
calcium en favorisant la formation de cristaux d'urate mono- 
sodique et d'acide urique qui agissent comme germe de cristalli- 
sation pour I'oxalate de calcium ou bien adsorbent les inhibiteurs 
macromoleculaires physiologiques de la cristallisation de 
l'oxalate de calcium. Les deux mecanismes exigent une sursatu- 
ration des urines en ce qui concerne I'acide urique, mais cela n'a 
pas encore C t e  etudik dans de conditions de vie normale. Nous 
avons mesure la saturation en ce qui concerne I'urate acide de 
sodium et les concentralions d'acide urique non dissocik dans les 
urines de 67 malades atteints de lithiase calcique qui avaient une 
hypercalciurie idiopathique, une hyperuricosurie, les deux dk- 
sordres, ou encore aucun de ces desordres. Les patients atteints 
d'hypenlricosurie elaborent une urine qui est plus souvent sursa- 
turee, en ce qui concerne I'urate monosodique ou I'acide urique 
non dissocie, que celie des autres individus lithiasiques ou nor- 
rnaux. Les malades son1 donc exposes h un plus grand risque de 
formation d'une phase solide d'urate monosodique ou d'acide 
urique. Les mesures therapeutiques qui abaissent I'excrCtion 
d'acide urique diminuent aussi la sursaturation de I'urine, et ceci 
peut etrc la raison pour laquelle de tels traitements tendent a 
empicher la recidive de la lithiase calcique. 
Hyperuricosuria appears to contribute to the gen- 
esis of calcium oxalate renal stones 11-51, but the 
mechanisms by which it does this are not yet estab- 
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lished. One possibility is that uric acid or sodium 
hydrogen urate crystals form in the urine or renal 
tubules, because of hyperuricosuria, and act as seed 
crystals on whose surfaces crystals of calcium oxa- 
late may form [4, 51. This theory is supported by the 
fact that crystals of sodium hydrogen urate and, to a 
lesser extent, of uric acid are heterogeneous seed 
nuclei for calcium oxalate [6, 71. An alternative the- 
ory [8] is that excessive supersaturation leads to 
production of a colloidal phase of uric acid or 
monosodium urate that adsorbs, and thereby re- 
moves from solution, the highly charged macronio- 
lecular inhibitors of calcium oxalate crystal growth 
that normally [8- 101 protect against calcium oxalate 
crystallization. Both theories require that urine be- 
come excessively supersaturated with uric acid or 
sodium hydrogen urate as a consequence of hyper- 
uricosuria. 
Pak et a1 [9, 111 have established that hypcr- 
uricosuria can raise the urine's saturation with re- 
spect to sodium hydrogen urate under conditions of 
controlled sodium and water intake, and at a con- 
stant urine pH. These positive findings make it 
worthwhile to determine the extent to which hyper- 
uricosuria causes oversaturation under routine. out- 
patient conditions, in which urine pH, volume, so- 
dium concentration, and uric acid concentration are 
all conditioned by the individual habits of the 
patient. 
Methods 
Pntienis crtltl tlorn7cil subjecis. Using our usual 
clinical and laboratory protocol [3], we studied 67 
consecutive patients, 45 men and 22 women ranging 
in age from 17 to 72 years. All of them had formed at 
least one calcium stone and had either idiopathic 
hypercalciuria, hyperuricosuria, both, or neither 
disorder. Idiopathic hypercalciuria was defined by a 
daily urinary calcium excretion above 300 rng 
(men), 250 rng (women), or above 4 mg/kg (either 
sex), normocalcemia, and the absence of a specific 
cause for hypercalciuria [12, 131. Diagnostic criteria 
for hyperuricosuria were a daily urinary uric acid 
excretion above 800 mg (men) or 750 mg (women) 
[I-31. In addition, we studied the 24-hour collec- 
tions from 10 normal men and 10 normal women 
(ages, 24 to 50 years). Each patient collected three 
24-hour urine samples, with thymol as a pre- 
servative [3], under outpatient conditions. Each pa- 
tient was on the diet of his choice. A blood sample 
was obtained at the completion of each collection, 
in the postabsorptive state. Urine samples that ap- 
peared grossly infected or had a pH value of above 
8 were rejected. 
Saturation measurements .for sodium hydrogen 
urnre. Two samples from each 24-hour urine collec- 
tion were seeded with 5 mgtml of sodium hydrogen 
urate monohydrate crystals, prepared by us [6, 71. 
Six drops of chloroform were also added, to control 
bacterial growth. The pH was adjusted back to its 
original value, during incubation, using 1.0 M so- 
dium hydroxide. After the samples were incubated 
at 37" C for 48 hours, at a constant pH, the solid and 
liquid phases were separated by filtration through a 
0.22-p pore diameter filter. Pak et al[9] have shown 
that this filter gives results identical to those using a 
filter of 0.05-p pore diameter. Sodium and uric acid 
concentrations were measured in the filtrate, as well 
as in the original urine sample, and the ratio of the 
initial to the final product of the sodium and uric 
acid concentrations was calculated [ l  I]. If duplicate 
values of the concentration ratio differed by more 
than 10%, the sample was discarded. In addition to 
measuring the concentration product ratio at the 
ambient pH of the urine, we also measured it at a 
controlled pH, of 6.3 to 6.5, in 76 urine samples, 
from 28 of the 67 patients. Unless specified, all satu- 
ration results refer to those obtained at the ambient 
urine pH. The concentration product ratio was mea- 
sured in urine samples from 16 of the 20 normal sub- 
jects. Because the concentration product after 2 
days of incubation represents the final equilibrium 
value for that urine sample [9, 1 I], the ratio of the 
preincubation to the postincubation product is es- 
sentially the ratio of the ion product in the original 
urine sample to the equilibrium product in that urine 
sample [ll].  Values above 1 indicate growth of the 
seed crystals, and therefore supersaturation; values 
below 1 reflect undersaturation. 
Undissociarrd uric acid. The concentration of 
undissociated uric acid (A) was calculated for each 
24-hour urine sample by the equation 
[A] = [TI + ( 1  + 
where T is the total uric acid concentration of the 
urine. The value of pK (5.345) was obtained by cor- 
recting the thermodynamic dissociation constant 
(pK, 5.47) [I41 by the monovalent ion activity coef- 
ficient for urine, which, at the ionic strength charac- 
teristic of urine, is close to 0.75 [15]. Twenty-six 
urine samples that had a pH of below 5.6 were seed- 
ed with 5 mglml of uric acid crystals prepared by us 
[7], to determine uric acid solubility; each sample 
was studied in duplicate. After 48 hours of in- 
cubation, with stirring, at 37" C and constant pH, 
the urine was filtered through a 0.22-p filter and cal- 
culated the undissociated uric acid concentration of 
the filtrate. The mean equilibrium concentration 
was 90 + (SEM) 5 mdliter. The mean ratio of the 
initial to the final concentration, an estimate of the 
degree of supersaturation in each urine, was 2.41 2 
0.2 and was correlated closely (r = 0.81) with the 
initial urine undissociated uric acid concentration. 
Calciunl oxalate satrrmtion. The concentration 
product ratio for calcium oxalate monohydrate was 
measured in each urine sample by the method of 
Pak and Holt [16], as described from our laboratory 
[17]. Previously, we have determined a range of 
normal to be from 0.6 to 2.85 for this test, close to 
that reported by Pak [16]. Patients whose mean val- 
ue exceed 2.85 were classified as having abnormally 
elevated calcium oxalate supersaturation. 
Analyrical mrthods and materials. Serum and 
urinary uric acid concentration was measured by 
the uricase method; sodium, by flame photometry 
[ l ,  31. Serum and urinary calcium concentrations 
were measured by atomic absorption spectro- 
photometry [12]; and urine oxalate, by zinc reduc- 
tion [17, 181. Crystals of sodium hydrogen urate, of 
uric acid, and of calcium oxalate.H,O were con- 
firmed by X-ray crystallography. 
Statistics and notnrnclature. Confidence limits, t 
values, and regression equations were calculated by 
the least squares method by a standard computer 
program (BMDP, U .C.L.A. Health Sciences Com- 
puting Facility, Los Angeles, California). In the 
case of urine pH, values of urinary proton concen- 
tration were used for calculating the means and Stu- 
dent's t values for comparison of patients to nor- 
mal; the pH values of the mean proton concentra- 
tions are presented because they are a familiar 
index. 
Results 
Sodium hydrogen urate satlrrmtion. Mean values 
of the urinary concentration product ratio (CPR) 
were not different for patients and normal subjects 
Coe er 01 
(Table I), even though the urinary concentration of 
uric acid was higher in hyperuricosuric patients. 
The CPR of hypercalciuric and metabolicaliy nor- 
mal stone formers tended to be lower than that of 
hyperuricosuric patients or normal people. The 
urine volume was higher than the control value 
among hypercalciuric and hyperuricosuric patients. 
The final, postincubation, concentration products 
were all within a narrow range of between 11.0 and 
13.2~" 10-"Table I), and therefore the CPR was 
very closely correlated (Fig. 1) with the initial uric 
acid concentration (r = 0.70), the initial urate con- 
centration (r = 0.79), the initial sodium concentra- 
tion (r = 0.68), and the initial product of urate and 
sodium concentrations (r = 0.85). All values of r are 
significant at P < 0.01. Judging from the 95% con- 
fidence limits, which were calculated for use with 
the means of three separate samples, we found that 
a patient whose mean initial uric acid concentration 
exceeds 860 mg/liter (Fig. 1) will have an average 
concentration product ratio below 3 less than 5% of 
the time, whereas patients whose corresponding 
mean values are below 350 mglliter will have a mean 
that exceeds 3 less than 5% of the time. The mean 
postincubation concentration products exceeded 
the mean postincubation activity product for urine 
(3.45 + 0.7 M~ X observed by Pak et a1 [I  I], as 
expected. 
In the present study, urine pH was often below 6 
(Table l), rather than between 6.3 and 6.5 as in pre- 
vious studies [9, 1 I]. To estimate the effect of this 
pH dzerence, we compared the concentration 
product ratio values of 76 urine samples, having a 
pH below 6.0, from 28 patients, incubated at their 
ambient pH and at a controlled pH of 6.3 to 6.5. The 
means (& 1 SEM) of the dzerences between the con- 
trolled pH and the ambient pH values for the con- 
centration product ratio were 0.33 * 0.15, 0.7 -c 
O.l3,0.45 r 0.22, and 0.21 -t- 0.15 for urine samples 
from patients with idiopathic hypercalciuria (30 
samples), hyperuricosuria (1 1 samples), both (9 
samples), and neither disorder (26 samples), respec- 
tively. The corresponding mean increments in urine 
pH (controlled pH - ambient pH) were 0.45, 0.45, 
0.48, and 0.44 pH units, respectively. In other 
words, a systematic overestimate of the concentra- 
tion product ratio occurred when these urine sam- 
ples were incubated at a higher pH; but the change 
was small, and attained statistical significance (t = 
2.146, P < 0.05) only for the 30 samples from pa- 
tients with idiopathic hypercalciuria. 
Men and women differed significantly from one 
another with respect to six findings (Table I): the 
undissociated uric acid for normals was 77 vs. 41 
mglliter for men and women, respectively; the so- 
dium concentration was 148 vs. 116 mEqilitcr (nor- 
Table 1. Summary of urinary uric acid saturation measurementsa 
Metabolic group 
24-Hour Normal IH HU Both Neither 
urine values (N = 20) (I\' = 24) (IV - 12) (N = 14) (N = 17) 
No. of samples 24 69 36 42 51 
Total uric acid, mgllirer 503 t 32 421 & 23 575 k 28 616 + 2F 462 2 32 
Urine volume, ml 1268 2 65 1717 t 133h*J 1501 + 79' 1397 t 70 1387 r 90 
Urine pH 6.22 5.92 5.62' 5.74g 5.67h 
Undissociated uric acid" mmglliier 57 k 8' 84 r?- I1 155 +211' 150 2 16' 128 2 18* 
CPK, monosodium urate 2.8 k 0.3P 2.2 z 0.2 2 . 7 k  0.2 3.1 2 0.2 2.2 -+ 0.2 
Initial [Na] . [urate]', M' X 37 2 4 27 rt 3 35 .C 4 42 r 3' 29 r 3 
Final [Na] . [urate]", ,w4 x 13.2 ? 0.7 11.0 r 0.5 12.0 + 0.6 12.9 .C 0.5 13.2 r 1.0 
Sodium concentration, mEqllirer 13 1 -r 8' 118 rt 7 130 + 7 149 rt 7k 132 k 7' 
- 
a All values, except for the numbers of samples and the numbers of people in each metabolic group (in parentheses), are the means 2 
SEM. Abbreviations used are: IH, idiopathic hypercalciuria; HU, hyperuricosuria; CPK, concentration product ratio; [Na], sodium 
concentration (mEqlliter); [urate], urdte concentration (mmolediter). 
The mean equilibrium value, determined in 26 urine samples of pH below 5.6, after 48 hours of incubation with crystals of uric acid, 
was 90 2 5 mgfliter. 
Before incubation with crystals of sodium hydrogen urate 
After 48 hours of incubation with crystals of sodium hydrogen urate 
Based upon the study of the 16 of the 20 normal subjects who had CPK measurements 
' P < 0.05. compared with control. 
P < 0.02, compared with control. 
P < 0.01, compared with control. 
' P < 0.001, compared with control. 
j P < 0.05, men vs. women. 
P < 0.02, men vs. women. 
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Fig. 1. Correlntion between the urine sodium hydrogen urate concenrratiun product ruriu (CPR) and rord uric ucid corrcentrcction. 
Symbols are: A ,  normal subjects; 0, idiopathic hypercalciuria; 0, hyperuricosuria; 0, both; *, neither. The regression has a slope of 4.87 
x lW3 and an intercept of 0.O56. The confidence interval is calculated so that the likelihood that the mean value from three samples from 
the data will be outside of the intcrval is lcss than 5%. Eachpoin~ represents a single urine sample. Mean values are shown in Table I .  
mals), 157 vs. 115 mEq/liter (both), 142 vs. 113 
mEqlliter (neither); the initial [Na] . [urate] was 45 
vs. 30 d X 10-5 (both); and the urine volume for 
idiopathic hypercalciuria was 1986 vs. 1415 ml. 
None of these difierences affect any conclusions, in 
that comparison of normals to patients of the same 
sex are indistinguishable statistically from com- 
parison based upon pooled data from men and 
women. 
Undissociated uric acid concentration. Unlike 
the situation with sodium hydrogen urate, stone 
formers who were hyperuricosuric produced urine 
samples whose mean concentrations of undisso- 
ciated uric acid were about 100 mgtliter higher than 
normal (Table I). The majority of the increase was 
due to low urine pH; the mean concentrations of 
undissociated uric acid were more than twice nor- 
mal in hyperuricosuric patients even though the 
mean concentration of total uric acid in the urine of 
stone formers who were hyperuricosuric (575 mg/ 
liter) or hyperuricosuric and hypercalciuric (616 mg/ 
liter) exceeded that of normals by only 14.3% and 
22.5%, respectively. Note that the exact mean val- 
ues of undissociated uric acid shown in Table 1 can- 
not be calculated from the corresponding mean val- 
ues for pH and total uric acid concentration because 
the relationship between pH and the ratio of un- 
dissociated to total uric acid is nonlinear. Patients 
with no metabolic disorder also had an average uri- 
nary undissociated uric acid concentration above 
that of normal people (Table 1) even though their 
average total uric acid concentration in urine was 
below that of normal subjects. 
Supersaturation in individual parients . To clas- 
sify patients in a preliminary way, we adopted some 
arbitrary upper limits for the concentration product 
ratio and for the undissociated uric acid concentra- 
tion. Only 4 normal subjects had mean values of 
CPR above 3.2 (4.0 to 6.7), and there was a notice- 
able break between 3.2 and 4.0 in the normal group 
and in all of the patients except those with com- 
bined hypercalciuria and hyperuricosuria. So, 
counting statistics would not be changed drastical- 
ly, for the most part, if we chose any value in this 
range as a limit. We have therefore used a mean 
value of 3.2 as a provisional upper limit for CPK. In 
the case of undissociated uric acid, no normal val- 
ues were above 138 mglliter, and this value was 2 SD 
above the normal mean (57 + [SD] 40) and is consid- 
erably above the equilibrium solubility of undisso- 
ciated uric acid in water at 37" C [19]. Accordingly, 
we have classified patients whose mean urinary 
concentration of undissociated uric acid was above 
138 mgtliter as having high, as opposed to unre- 
markable, values. 
Using these limits, we found high values for the 
concentration product ratio and for the undisso- 
ciated uric acid, alone or with other abnormalities, 
in 32 of the 67 patients, 47.8% (Table 2); they would 
be expected to occur together by independent 
chance association in 8.71% of patients, or 5.8 pa- 
tients in this series, not significantly different from 
the eight instances we observed. Of interest, five of 
the eight instances of their concurrence were in the 
14 patients with combined hypercalciuria and hy- 
peruricosuria (Table 2), compared to only three in 
the remaining 53 patients (x2 = 9.53, P < 0.01). 
Overall, there were 18 patients with abnormally 
high supersaturation of undissociated uric acid and 
sodium hydrogen urate among the 26 patients who 
were hyperuricosuric, compared to only 14 among 
41 patients who were not hyperuricosuric (x2 = 7.8, 
P < 0.01), and 4 of 16 normal subjects (x' = 7.77, P 
< 0.01), so that hyperuricosuria was associated 
with excessive uric acid supersaturation. 
Elevated mean urine calcium oxalate concentra- 
tion product ratios (above 2.85, Methods) were 
found in 17 of the 67 patients (25%), 10 of whom 
(58.8%) were hypercalciuric; 7 of these 17 patients 
also had a high mean sodium hydrogen urate con- 
centration product ratio (Table 2), a concurrence 
rate compatible with chance alone. 
Eflecrs of rrearmenr. Sixteen patients with hyper- 
uricosuria, seven of whom also were hypercalciuric, 
were treated with allopurinol, 100 mg twice daily, or 
a low purine diet to lower their 24-hour urine uric 
acid excretion below 800 mg; some of the 
with hypercalciuria also received trichlormethia- 
zide, 2 mg twice daily, to lower their urine 
calcium excretion [3] (Fig. 2). Urinary uric acid 
Table 2. Occurrence of elevated uric acid or calcium 
supersaturiition in each metabolic classa 
Urine Metabolic class 
saturation increased 
with respect to  IH HU Both Neither Totals 
Undissociated uric acid" 2 4  3 5 14 
Monosodium urateP 1 2  l 0 4 
Both 2 0  3 1 6 
Calcium oxslate . H@" 4 1  0 4 9 
Calcium oxalate . H,O 
and monosodium urate 2 1  I 1 5 
Calcium oxalate . H,O and 
undissociated uric acid 0 0  I 0 1 
Calcium oxalate . H,O 
and monosodium urate 
and undissociated u r ~ c  acid 0 0 2 0 2 
None 13 4 3 6 26 
Torol porients 24 12 14 17 67 
" Table shows the number of patients whose mean urine values 
exceeded the upper limits used in this study: Abbreviations: IH,  
idiopathic hypercalciuria: HU.  hyperuricosuria. 
" Mean value exceeds 138 mg/liter. 
Mean value exceeds 3.2. 
W e a n  value exceeds 2.85. 
Pretreatment CPR sodium hydrogen urate 
Pretreatment undissociated uric acid, mg/l!ter 
Fig. 2. Response of urine scirurarion ro rreotmc,nr. The difference 
between the mean initial value and the last treatment valuc of 
monosodium urate concentration product ratlo ( t i )  and undisso- 
ciated uric acid (b )  are plotted against corresponding mean prc- 
treatment values for 9 patients with hyperuricosuria (closed syv-  
bols) and 7 patients with combined hypercalciuria and hyper- 
uricosuria (open symbols). treated with allopurinol (circles~ or 
low purine diet alone (scprcrres). Some patients with both hyprr- 
calciuria and hyperuricosuria, and one patient with only hyper- 
uricosuria, also received trichlormethiazide (2 mg, twice a day) 
(indicated by a line rhrorrgh rlze synlbol). 
saturation fell; the extent of the fall was strong- 
ly correlated with the magnitude of the mean prc- 
treatment value for both the sodium hydrogen urate 
concentration product ratio (Fig. 2a) (r = -0.80) 
and the urinary undissociated uric acid concentra- 
tion (r = -0.76). Undissociated uric acid concentra- 
tion (Fig. 2b) remained above 138 mgiliter in only 
four instances, and the concentration product ratio 
fell below 3 in all but one case. Mean values of un- 
dissociated uric acid fell to 65 2 20 and 95 f 30 mg! 
liter for patients with hyperuricosuria and combined 
hyperuricosuria and hypercalciuria, close to the 
mean value observed in normal people (Table I). 
Discussion 
The primary question to which we have ad- 
dressed ourselves in this study was whether o ~ -  not 
hyperuricosuria leads to abnormally high urinary 
supersaturation with uric acid under uncontrolled, 
ambient conditions of diet, fluid intake, and life style. 
The answer seems clearly positive. Of our 26 hyper- 
uricosuric patients, 18 (69rA) displayed excessive 
supersaturation with uric acid or sodium hydrogen 
urate compared to 14 of 41 (34%) patients who were 
not hyperuricosuric (x2 = 7.84, P < 0.01), and 4 of 
the 16 normal people in whom both the concentra- 
tion product ratio and undissociated uric acid con- 
centration were measured (x' = 7.77, P < 0.01). Ex- 
cessive uric acid and calcium oxalate super- 
saturation occurred as if they were independent of 
one another, as are hyperuricosuria and hyper- 
calciuria [3]. 
As Pak et a1 [9, 1 I] have found, sodium hydrogen 
urate saturation varies strongly with urinary uric 
acid concentration, which was high in hyper- 
uricosuric patients. The slope and the intercept of 
the regression equation (Fig. 1) between them are 
both higher in  this study than they are in the study 
of Pak et al, probably because the urinary sodium 
concentration in the Pak study was held at about 50 
mEq/liter, compared to our mean values of 118 to 
149 mEq/liter (Table I ) .  Unlike Pak et al [13], we 
found undersaturation, values of the concentration 
product ratio below 1.0, only rarely, whereas they 
found it to be common when urine uric acid concen- 
tration was below 300 mgtliter. This difference, too, 
is probably due mainly to the higher sodium con- 
centrations we encountered. In addition, we found 
very few values of total urinary uric acid concentra- 
tion below 300 mdliter, whereas many values were 
above 500 mgtliter, the upper limit achieved by Pak 
et a1 under controlled circumstances. Apparently, 
spontaneous conditions of diet and fluid intake lead 
to even higher values of total uric acid concentra- 
tion and sodium excretion than those encountered 
under controlled conditions, even though urine vol- 
umes were higher among several groups of patients 
than they were among controls, so that urine is usu- 
ally supersaturated with respect to monosodium 
urate. 
Elevated urinary undissociated uric acid concen- 
tration was a striking feature of our stone formers 
and was due more to low urine pH than to a high 
urinary total uric acid concentration. 
The low urine pH may have arisen, in part, from 
diet. In calcium stone formers, hyperuricosuria is 
produced mainly by a high intake of meat, fish, and 
poultry [2, 201, and all three foods impose a large 
load of acid, in the form of phosphoric and sulfuric 
acids, for eventual excretion [21]. This does not, 
however. explain why patients without hyper- 
uricosuria or hypercalciuria (Table 1)  also had a low 
average urine pH. 
Increased undissociated uric acid concentrations 
can foster the formation of uric acid crystals, which 
can act as heterogeneous seeds for calcium oxalate 
[7]. Even if they were very inefficient hetero- 
geneous nuclei, uric acid crystals that plug the end 
of a collecting duct [22] could, in theory, serve as an 
anchored site on which a plaque of calcium oxalate 
crystals might form. Alternatively, a gel phase of 
uric acid may be able to adsorb macromolecular in- 
hibitors of crystal growth. In support of a link be- 
tween uric acid crystals and calcium nephrolithiasis 
are the facts that patients with gout, who produce 
very acid urine, form an excess of calcium [23, 241 
as well as uric acid stones, and that mixed stones, of 
calcium oxalate and uric acid, are not a rare occur- 
rence among nongouty patients with combined hy- 
percalciuria and hyperuricosuria or no metabolic 
defect [25]. 
From our study, treatment measures that lower 
uric acid excretion also reduce uric acid saturation, 
with respect to the undissociated uric acid and the 
monosodium urate solid phases, and therefore 
could reduce heterogeneous nucleation or the ad- 
sorption of crystal growth inhibitors by solid phases 
of uric acid or its monosodium salt. The response 
was excellent for undissociated uric acid, even 
though we did not attempt to increase urine pH by 
our treatment. The excellent response of super- 
saturation to treatment with allopurinol or reduced 
purine intake is consistent with the dramatic reduc- 
tion in calcium stone recurrence that has been 
found in treated patients [I-3, 261. 
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